Follow
Femi Oshagbemi
Femi Oshagbemi
M.Pharm, MPH, PhD
No verified email
Title
Cited by
Cited by
Year
Stability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline counts
OA Oshagbemi, AM Burden, DCW Braeken, Y Henskens, EFM Wouters, ...
American journal of respiratory and critical care medicine 195 (10), 1402-1404, 2017
1062017
Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality
OA Oshagbemi, FME Franssen, DCW Braeken, Y Henskens, ...
Pharmacoepidemiology and drug safety 27 (11), 1191-1199, 2018
252018
Blood eosinophil counts, withdrawal of inhaled corticosteroids and risk of COPD exacerbations and mortality in the Clinical Practice Research Datalink (CPRD)
OA Oshagbemi, FME Franssen, S van Kraaij, DCW Braeken, ...
COPD: Journal of Chronic Obstructive Pulmonary Disease 16 (2), 152-159, 2019
222019
Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis
OA Oshagbemi, JHM Driessen, A Pieffers, EFM Wouters, P Geusens, ...
Osteoporosis International 28, 2859-2866, 2017
212017
Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary disease
OA Oshagbemi, AM Burden, KN Shudofsky, JHM Driessen, P Vestergaard, ...
Bone 110, 238-243, 2018
172018
Absolute blood eosinophil counts to guide inhaled corticosteroids therapy among patients with COPD: systematic review and meta-analysis
OA Oshagbemi, JO Odiba, A Daniel, I Yunusa
Current Drug Targets 20 (16), 1670-1679, 2019
142019
Retinal vasculitis or vascular occlusion after brolucizumab for neovascular age-related macular degeneration: a systematic review of real-world evidence
CC Wykoff, H Matsumoto, MR Barakat, H Karcher, A Lozama, A Mayhook, ...
Retina, 10.1097, 2022
102022
Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013
OA Oshagbemi, SJ Keene, JHM Driessen, R Jordan, EFM Wouters, ...
Respiratory Medicine 144, 1-6, 2018
92018
Stability of blood eosinophils in COPD and controls and the impact of gender, age, smoking and baseline counts
OA Oshagbemi, AM Burden, M Braeken, Y Henskens, EF Wouters, ...
Am J Respir Crit Care Med 195 (10), 1402-1404, 2017
62017
C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPD
OA Oshagbemi, FME Franssen, EFM Wouters, AH Maitland-van der Zee, ...
Pulmonary pharmacology & therapeutics 60, 101870, 2020
22020
Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: the effect of index date selection?
JTH Nielen, O Oshagbemi, F de Vries, AM Burden
Annals of the rheumatic diseases 75 (5), e26-e26, 2016
22016
Estimated distribution of malaria cases among children in sub-Saharan Africa by specified age categories using data from the Global Burden of Diseases 2019
OA Oshagbemi, P Lopez-Romero, C Winnips, KR Csermak, G Su, ...
Malaria Journal 22 (1), 371, 2023
12023
The role of misclassification of exposure in the association between aspirin and nonsteroidal anti‐inflammatory drug use and keratinocyte cancers.
S Abtahi, OA Oshagbemi, A Veelen, R Geel
British Journal of Dermatology 181 (3), 2019
12019
Retrospective study estimating the incidence of acute alcoholic hepatitis in the United Kingdom
OA Oshagbemi, MN Ribeiro, S Behr, O Zorina
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 511-511, 2022
2022
Second-generation antipsychotics and pregnancy complications: the impact of confounding by indication
OA Oshagbemi, A Daniel, I Yunusa
European Journal of Clinical Pharmacology 77, 439-440, 2021
2021
Impact of Average Daily and Cumulative Dose of Statins on Mortality Risk Among Healthy Elderly
S Abtahi, OA Oshagbemi, A van Veelen
The American Journal of Medicine 132 (7), e621, 2019
2019
Biomarkers in real-life COPD management
OA Oshagbemi
2019
The system can't perform the operation now. Try again later.
Articles 1–17